(© https://de.123rf.com/profile_parilovv and © mixed with company logo®)
Langenfeld (rhld.) – Germany, 2022-08-18
Today, we will focus our attention on the “entourage effect” and the important role of “terpenes” in cannabis therapy according to existing scientific research.
Short flashback: The “entourage effect” was first described by Dr. Ben-Shabat in 1998 and was explained and expanded upon in particular by Dr. Ethan Russo. Dr. Ethan Russo, M.D., a neurologist who has long studied cannabis active ingredients and their role in the body extensively, published the following study in 2011: “Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects”
Natural Pharma‘s stance on the “entourage effect” is:
Especially in the medical field, “entourage effect” should not be disregarded. Our partner Beacon Medical Germany, a German subsidiary of the Canadian company VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF), focuses on high-quality and full transparency of the imported cannabis products to Germany. In order to achieve full transparency, we offer in addition to our COA, an up-to-date terpene analysis for each batch. This enables the treating physicians and especially the patients to provide a targeted therapy. Proverb: Entourage effect.
Therefore, we would like to share with you our achievement:
Our partner product, Beacon Indica THC 20 – Sensi Star (Batch 1251SI31401) has been measured and confirmed by a German testing laboratory with a terpene concentration of 2.92%.
In Germany, no one except us offers an up-to-date terpene analysis for the available batches. The reason is, in Germany it is not mandatory to provide terpene information. But with exception of THC and CBD according to the German Pharmacopoeia (DAB).
We placed great emphasis with VIVO Cannabis® and Beacon Medical Germany to provide a transparent medical cannabis product, which has allowed us to gain more and more trust from physicians and patients in Germany.
Further medical cannabis products from VIVO’s large portfolio will follow. Which Canadian products these will be, this is a secret of the companies for the time being.
But we can tell you one thing:
We will continue to introduce transparent medical cannabis products.
PR-Contact for Natural Pharma
Dr. Daniel König
+49 (0) 2173 940 95 91
press(ät)natpha.com
About Natural Pharma
Natural Pharma Resource (Natural Pharma) GmbH was founded at the beginning of 2022 and is based in Langenfeld, Germany.
The pharmaceutical and biotechnological company focuses on the import, storage, manufacturing, distribution and export of pharmaceutical products, preparations and substances, in particular medicinal products under the German Medicines Act (AMG), narcotics under the German Narcotics Act (BtMG) and cannabis for medicinal purposes as well as research and development in this field.
We are licensed pharmaceutical wholesalers according to § 52a of the German Medicines Act (AMG) and have a permit to handle narcotics according to § 3 of the Federal Institute for Drugs and Medical Devices (BtMG).
For more information, visit: Natural Pharma
About VIVO Cannabis
VIVO Cannabis® is recognized for trusted, premium cannabis products and services. Through its Canna Farms and ABcann business units, VIVO holds production and sales licences from Health Canada and operates world-class indoor cultivation facilities. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms™, Beacon Medical®, Fireside™, and Lumina™. Harvest Medicine™, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 200,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia.
For more information, visit: VIVO Cannabis Inc. and Beacon Medical Germany.
Business partner
Become a partner of us and participate proactively with your resources in the supply chain of the German market for medical and recreational cannabis. As partner and company we can offer security, continuity, transparency and trust.